Biotech and Pharmaceuticals
Poliovirus found in Brooklyn and Queens sewage, New York health officials say
Polio virus particle, computer illustration. Kateryna Kon | Science Photo Library | Getty Images New York Gov. Kathy Hochul has extended the state of emergency declared in response to the spread of poliovirus after sewage tested positive in Brooklyn and Queens. Hochul said the state disaster emergency will remain in place at least through Nov. […]
Read More
A series of mega-blockbuster drugs are on the horizon. How to invest in the trend
Biopharma companies are having more clinical success treating Alzheimer’s disease and obesity and are taking new approaches in oncology, and that’s creating more mega-blockbuster drugs, according to Bank of America. Analyst Geoff Meacham has identified 20 drugs that have the potential to generate $10 billion or more in annual sales by 2030 within the universe […]
Read More
FDA clears vaccine to prevent whooping cough in newborns by giving shot to mother during pregnancy
Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, August 29, 2020. Andrew Kelly | Reuters The Food and Drug Administration on Friday approved a vaccine for use in the third trimester of pregnancy to prevent whooping cough in newborn infants. The vaccine, called Boostrix, is made by […]
Read More
Covid vaccines prevented at least 330,000 deaths among U.S. seniors in 2021, health officials say
Covid vaccines prevented at least 330,000 deaths and nearly 700,000 hospitalizations among adult Medicare recipients in 2021, the Health and Human Services Department said in a new report published Friday. The reduction in hospitalizations due to vaccination saved more than $16 billion in medical costs, according to the HHS report. A 10% increase in vaccination […]
Read More
U.S. will display people arriving from Uganda for Ebola as East African nation battles outbreak
Medical practitioners wander inside of the Ebola isolation portion of Mubende Regional Referral Healthcare facility, in Mubende, Uganda, Thursday, Sept. 29, 2022. Hajarah Nalwadda | AP The U.S. will rout and display travellers for Ebola at five selected airports if they have traveled in Uganda within just a few months prior to their arrival, federal […]
Read More
Eli Lilly’s 2022 gains grow to 20% as it lays out plan for possibly the most successful drug ever
Eli Lilly’s obesity treatment tirzepatide has been granted “fast track” status by the Food and Drug Administration, which means it could win approval as early as late 2023. The drug, which was already approved to treat type 2 diabetes under the name Mounjaro in May, has the potential to be a blockbuster, analysts have said. […]
Read More
How polio came back to New York for the first time in decades, silently spread and left a patient paralyzed
A research assistant prepares a PCR reaction for polio at a lab at Queens College on August 25, 2022, in New York City. Angela Weiss | AFP | Getty Images When a young adult in a New York City suburb visited an emergency department in June after experiencing weakness in their lower legs, the shocking […]
Read More
Monkeypox eradication unlikely in the U.S. as virus could spread indefinitely, CDC says
The monkeypox virus is unlikely to be eliminated from the U.S. in the near future, according to a report published by the Centers for Disease Control and Prevention this week. The CDC, in a technical brief, said the outbreak is slowing as the availability of vaccines has increased, people have become more aware of how […]
Read More
Ohio reports third U.S. death of person with monkeypox who had underlying health conditions
A Northwell Health staff member holds the monkeypox vaccine, at Cherry Grove on Fire Island, New York, where monkey pox vaccines were administered on July 14, 2022. James Carbone | Newsday | Getty Images Health authorities in Ohio reported the death of an adult male who had monkeypox, the third fatality in the United States […]
Read More
FDA approves controversial new drug designed to slow the progression of ALS
The Food and Drug Administration on Thursday approved a controversial new drug designed to slow the progress of Lou Gehrig’s disease, a victory for patients and advocates despite limited evidence that the drug is effective. The drug, from the Massachusetts-based Amylyx Pharmaceuticals, joins only a handful of drugs approved by the agency for the fatal neurodegenerative disease […]
Read More